Statins for people at low risk of cardiovascular disease: Authors' reply

QR Code

Statins for people at low risk of cardiovascular disease: Authors' reply

Bibliographic Details
Main Authors:	Zomer, E., Owen, A., Magliano, D., Reid, Christopher
Format:	Journal Article
Published:	2012
Online Access:	http://hdl.handle.net/20.500.11937/44675

Similar Items

The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: Best case scenario analysis using a Markov model
by: Zomer, E., et al.
Published: (2012)

Author reply
by: Campbell, D., et al.
Published: (2013)

More or less physical activity and the effect on cardiovascular mortality in a high-risk population
by: Zomer, E., et al.
Published: (2011)

Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: The 'old' versus the 'new' Framingham equation
by: Zomer, E., et al.
Published: (2011)

Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms
by: Zomer, E., et al.
Published: (2014)

Prevention of Cardiovascular Disease
by: Owen, A., et al.
Published: (2012)

Epidemiology of cardiovascular disease
by: Reid, Christopher, et al.
Published: (2016)

Review on Cardiovascular Risk Prediction
by: Ruwanpathirana, T., et al.
Published: (2015)

Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults
by: Zhou, Z., et al.
Published: (2020)

Re: Authors' reply to Stockwell and colleagues
by: Daube, Mike
Published: (2012)

Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling
by: Ruwanpathirana, T., et al.
Published: (2015)

Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)

The Patterns Of Prescribing, Health Beliefs And Adherence To Statin Therapy Among Patients With High Cardiovascular Disease Risk And Health Care Providers’ Knowledge, Attitude, Barriers And Practice Regarding Cardiovascular Risk Assessment And Statin Therapy In Yemen
by: Al-Ashwal, Fahmi Yahya Ahmed
Published: (2022)

Neuraminidase inhibitors for influenza complications: authors' reply
by: Nguyen-Van-Tam, Jonathan S., et al.
Published: (2014)

Outcomes and excess costs among patients with cardiovascular disease
by: Ademi, Z., et al.
Published: (2013)

Expectant management in pregnancies with ruptured membranes – Authors' reply
by: Morris, Jonathan M., et al.
Published: (2016)

The child support grant and adolescent risk of HIV infection in South Africa – Authors' reply
by: Cluver, L., et al.
Published: (2014)

Cardiovascular risk prediction in healthy older people
by: Neumann, J.T., et al.
Published: (2022)

Risk factor management in a contemporary Australian population at increased cardiovascular disease risk
by: Campbell, D., et al.
Published: (2018)

Risk of Progression of Nonalbuminuric Diabetic Kidney Disease to End-Stage Renal Disease: The CRIC Study
by: Koye, D., et al.
Published: (2017)

Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis
by: Zomer, E., et al.
Published: (2013)

Inertia or inaction? blood pressure management and cardiovascular risk in diabetes
by: Owen, A., et al.
Published: (2009)

Comparison of vaccine efficacy must be based on good clinical data–Authors’ reply
by: Abdul Taib, Nur Asheila, et al.
Published: (2022)

Androgens And Cardiovascular Disease In Men
by: Yeap, B., et al.
Published: (2019)

Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study
by: Koye, D., et al.
Published: (2018)

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: Protocol for a randomised controlled trial in primary care (STAREE trial)
by: Zoungas, S., et al.
Published: (2023)

Cardiovascular disease in Australia: Calm before a new storm?
by: Reid, Christopher
Published: (2013)

Reply.
by: Adams, L., et al.
Published: (2015)

In reply
by: Hillman, D., et al.
Published: (2010)

Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial
by: Joseph, P., et al.
Published: (2018)

Incidence of chronic kidney disease among people with diabetes: A systematic review of observational studies
by: Koye, D., et al.
Published: (2017)

In reply
by: Ing, C., et al.
Published: (2015)

In reply
by: Said, J., et al.
Published: (2010)

Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
by: Chan, Arlene, et al.
Published: (2016)

Assessment of vitamin D and its association with cardiovascular disease risk factors in an adult migrant population: An audit of patient records at a Community Health Centre in Kensington, Melbourne, Australia
by: Ruwanpathirana, T., et al.
Published: (2014)

Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study
by: Dallywater, William, et al.
Published: (2015)

Reply
by: Spreckley, M., et al.
Published: (2009)

Physiotherapy and occupational therapy and mild to moderate Parkinson Disease — Reply
by: Clarke, Carl E., et al.
Published: (2016)

Author Reply: Refers to du Toit, R. et al., Eye Health in East Timor
by: Finger, Robert, et al.
Published: (2008)

Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease
by: Angell, B., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4k1m9vntaiv2v0l44d0n40o61j